[
    [
        {
            "time": "2023-03-15",
            "original_text": "HealthEquity (HQY) Q4 Earnings, Revenues Beat Estimates",
            "features": {
                "keywords": [
                    "HealthEquity",
                    "Q4",
                    "Earnings",
                    "Revenues",
                    "Beat",
                    "Estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "HealthEquity (HQY) Q4 Earnings, Revenues Beat Estimates",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Why You Should Add Surmodics (SRDX) to Your Portfolio Now",
            "features": {
                "keywords": [
                    "Surmodics",
                    "Portfolio",
                    "Add",
                    "Now"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "medical devices"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why You Should Add Surmodics (SRDX) to Your Portfolio Now",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "These 3 Zero-Effort Stocks Could Make You Rich",
            "features": {
                "keywords": [
                    "Zero-Effort",
                    "Stocks",
                    "Rich"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "These 3 Zero-Effort Stocks Could Make You Rich",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        }
    ]
]